8-K: Longevity Health Holdings Enacts 1-for-30 Reverse Stock Split

Longevity Health Holdings implemented a 1-for-30 reverse stock split to increase its stock price and maintain Nasdaq compliance.

Summary

• Longevity Health Holdings, Inc. enacted a 1-for-30 reverse stock split of its common stock, effective May 12, 2025, at 9:00 a.m. Eastern Time.
• The reverse stock split was approved by stockholders at a special meeting on March 24, 2025, and the decision to proceed was made by the Board of Directors.
• The company's common stock is expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market on May 14, 2025, under the ticker symbol XAGE.
• The reverse stock split reduced the number of outstanding shares from approximately 30.1 million to approximately 1 million.
• No fractional shares will be issued; instead, fractional shares will be rounded up to the nearest whole share.
• Proportional adjustments will be made to outstanding stock options, warrants, and the 2023 Equity Incentive Plan.
• The new CUSIP number for the common stock is 142922 129, while the CUSIP number for the warrants remains unchanged.
• The total number of authorized shares of common stock remains at 250,000,000 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the reverse stock split is a common corporate action, it often indicates underlying issues with the stock price and company valuation. The company is taking steps to remain compliant with listing requirements.

Positives

• The reverse stock split is intended to increase the company's stock price, which may help maintain Nasdaq compliance.
• Rounding up fractional shares to the nearest whole share ensures that no stockholder loses value due to the split.

Risks

• The press release includes a forward-looking statements disclaimer, noting that actual results could differ materially from expectations due to various risks and uncertainties.
• The company's future performance is subject to economic, business, and competitive factors, as detailed in their SEC filings.

Future Outlook

The company expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market on May 14, 2025.

Industry Context

Reverse stock splits are often used by companies to increase their stock price to meet minimum listing requirements or to make the stock more attractive to investors.

Comparison to Industry Standards

• Reverse stock splits are a relatively common corporate action, particularly for companies facing delisting from major exchanges.
• Many companies in similar situations, such as those in the biotechnology or small-cap sectors, have employed reverse stock splits to maintain compliance and improve investor perception.
• It is important to note that while a reverse stock split can temporarily boost the stock price, it does not fundamentally change the company's underlying business or financial health.

Stakeholder Impact

• Shareholders will see a reduction in the number of shares they hold, but the proportional ownership remains the same.
• The reverse stock split may impact the perceived value of the stock and could influence investor sentiment.

Next Steps

• The company's common stock will begin trading on a split-adjusted basis on Nasdaq on May 14, 2025.
• Stockholders holding pre-split shares electronically in book-entry form are not required to take any action to receive post-split shares.

Key Dates

Keywords

reverse stock split, Longevity Health Holdings, XAGE, common stock, Nasdaq, stock split, shares